Clinical characteristics of the patients studied
| Parameter . | CMV seropositive patients . | CMV seronegative patients . |
|---|---|---|
| No. of patients | 45 (61.6%) | 28 (38.4%) |
| Median age, y (range) | 74.6 (52-87) | 71.8 (56-89) |
| Sex | ||
| Male | 26 (53.7) | 17 (60.8%) |
| Female | 19 (46.3) | 11 (39.2%) |
| Stage of disease | ||
| Binet A | 29 (64.4%) | 18 (64.7%) |
| Binet B + C | 16 (35.6%) | 10 (35.3%) |
| Treatment | ||
| No history of therapy | 30 (66.6%) | 19 (70.3%) |
| Positive history | 15 (33.3%) | 8 (29.7%) |
| Complications (during study period) | ||
| Autoimmune phenomena | 2 | 3 |
| Zoster reactivation | 2 | NF |
| Pneumonia | 1 | NF |
| Shingles | 1 | NF |
| Guillain-Barre syndrome | 1 | NF |
| Other cancers | 4 | NF |
| Parameter . | CMV seropositive patients . | CMV seronegative patients . |
|---|---|---|
| No. of patients | 45 (61.6%) | 28 (38.4%) |
| Median age, y (range) | 74.6 (52-87) | 71.8 (56-89) |
| Sex | ||
| Male | 26 (53.7) | 17 (60.8%) |
| Female | 19 (46.3) | 11 (39.2%) |
| Stage of disease | ||
| Binet A | 29 (64.4%) | 18 (64.7%) |
| Binet B + C | 16 (35.6%) | 10 (35.3%) |
| Treatment | ||
| No history of therapy | 30 (66.6%) | 19 (70.3%) |
| Positive history | 15 (33.3%) | 8 (29.7%) |
| Complications (during study period) | ||
| Autoimmune phenomena | 2 | 3 |
| Zoster reactivation | 2 | NF |
| Pneumonia | 1 | NF |
| Shingles | 1 | NF |
| Guillain-Barre syndrome | 1 | NF |
| Other cancers | 4 | NF |
CMV indicates cytomegalovirus; and NF, not found.